Literature DB >> 3625037

Effect of apoE on triglyceride emulsion interaction with hepatocyte and hepatoma G2 cells.

B Oswald, S Quarfordt.   

Abstract

The uptake and internalization of a triglyceride emulsion by rat hepatocytes in culture less than 24 hr was either inhibited or uninfluenced by apoE. ApoE significantly increased the uptake of these emulsions in later cultures. Specific low density lipoprotein (LDL) binding was similar for hepatocyte monolayers prior to and after 24 hr. Rat hepatocytes in culture for 2 days, which were treated with collagenase, detached and then replated within 1 hr and were apoE-responsive in 2 hr. Heparin inhibited the apoE stimulation in both hepatocytes and hepatoma monolayers. Heparin wash of hepatocytes or hepatoma cells incubated with apoE-[14C]triolein emulsions at 4 degrees C resulted in a considerable loss in radiolabeled cell lipid. A similar wash after 37 degrees C incubations produced little loss suggesting internalization. Hepatocytes had lower affinity but similar apoE-emulsion binding capacity compared to hepatoma cells. Triolein emulsions with apoE were significantly more rapidly metabolized by the hepatocyte than unsupplemented emulsions. The apoE-mediated hepatocyte lipid uptake was inhibited by apoC proteins. High molar ratios of free fatty acid/albumin also suppressed hepatocyte apoE-mediated lipid uptake. Both rat high density lipoprotein (HDL) and LDL inhibited with a potency directly related to their content of apoE. Human LDL and HDL without apoE also inhibited the interaction with less potency than the rat lipoproteins. Human HDL inhibition was diminished after removal of apoC proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3625037

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

Authors:  I V Fuki; K M Kuhn; I R Lomazov; V L Rothman; G P Tuszynski; R V Iozzo; T L Swenson; E A Fisher; K J Williams
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

2.  Modulation of apolipoprotein E-mediated plasma clearance and cell uptake of emulsion particles by cholesteryl ester.

Authors:  H Saito; K Okuhira; N Tsuchimoto; A Vertut-Doi; C Matsumoto; T Tanimoto; S Okada; T Handa
Journal:  Lipids       Date:  2001-01       Impact factor: 1.880

3.  Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity.

Authors:  Evangelia Zvintzou; Marie Lhomme; Stella Chasapi; Serafoula Filou; Vassilis Theodoropoulos; Eva Xapapadaki; Anatol Kontush; George Spyroulias; Constantinos C Tellis; Alexandros D Tselepis; Caterina Constantinou; Kyriakos E Kypreos
Journal:  J Lipid Res       Date:  2017-07-12       Impact factor: 5.922

4.  Chylomicron-remnant uptake by freshly isolated hepatocytes. Effect of heparin and of hepatic triacylglycerol lipase.

Authors:  F Sultan; D Lagrange; X Le Liepvre; S Griglio
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

5.  Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes.

Authors:  P Diard; M I Malewiak; D Lagrange; S Griglio
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

6.  Cholesterol secretion from hepatocytes induced by triacylglycerol and apolipoprotein E.

Authors:  S H Quarfordt; B A Landis; M O Farouk; B S Oswald
Journal:  Lipids       Date:  1994-06       Impact factor: 1.880

7.  Effects of cholesterol and cholesteryl oleate on lipolysis and liver uptake of triglyceride/phosphatidylcholine emulsions in rats.

Authors:  T Handa; Y Eguchi; K Miyajima
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

8.  Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

Authors:  R C Kowal; J Herz; J L Goldstein; V Esser; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.